In this article, we will discuss the 12 High-Growth Micro-Cap Stocks to Buy Now.

Over the past few years, focus has been on large-cap stocks and the magnificent seven that have delivered spectacular returns. After three years of blockbuster gains, the trade is slowly coming under scrutiny amid concerns that markets are priced for perfection, with premium valuations in play.

Amid valuation concerns, a rotation away from large-cap stocks that have propelled the market to an all-time high is slowly brewing. Micro-cap stocks are increasingly showing extreme performance dispersion relative to the market. The cheap under-the-radar stocks are increasingly powering high, driven by innovation, niche industrial services, and specialized consumer segments.

Micro-caps tied to technological innovation and specialized consumer products have seen notable gains, as shown by the Russell Microcap index, which has rallied about 21% year to date. In contrast, the broader S&P 500 index has only gained 6% b over the same period.

Standing in the way of microcap and small-cap stocks rallying heading into year-end is growing concerns over the interest rate trajectory. Soaring inflation, driven by higher energy prices, has diminished the prospects of the US Federal Reserve cutting interest rates. Early in the year, David Royal, Thrivent Chief Financial & Investment Officer, warned that small companies would struggle without more interest rate cuts.

However, with the US appearing to have struck a deal with Iran, paving the way for the opening of the Strait of Hormuz, inflation could ease on energy flows, returning to normalcy. Inflation inching lower would make the case for lower interest rates, which would favor micro-cap stocks.

With that in mind, let’s take a look at the best high growth micro-cap stocks to buy now, likely to benefit from favorable macro conditions.

Our Methodology

To compile a list of the 12 High Growth Micro-Cap Stocks to Buy Now, we used Finviz and Yahoo Screener to scan for companies with a market cap of between $50 million and $300 million as of June 15. We also reviewed several micro‑cap growth stock ETFs, with the most notable being iShares Micro‑Cap ETF (IWC), First Trust Dow Jones Select MicroCap Index Fund (FDM), and Dimensional U.S. Micro Cap Portfolio ETF (DFMC). We trimmed the list to companies that have grown sales by over 10% over the past five years and are expected to grow earnings by over 20% over the same period. We also focused on stocks with upside potential of more than 20% and also detailed the number of hedge funds holding stakes in them in Q1 2026. Finally, we ranked the stocks in ascending order based on the number of hedge funds holding stakes in them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research shows we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

High-Growth Micro-Cap Stocks to Buy Now

12. Armata Pharmaceuticals Inc. (NYSE:ARMP)

Market Capitalization: $265.57 Million

Expected 5-Year Earnings Growth: 40.13%

Number of Hedge Fund Holders: 4

Stock Upside Potential: 130.87%

Armata Pharmaceuticals Inc. (NYSE:ARMP) is one of the high-growth micro-cap stocks to buy now. On May 7, Armata Pharmaceuticals Inc. (NYSE:ARMP) achieved a significant milestone when the U.S Food and Drug Administration granted Fast Track Designation to AP-SA02.

AP-SA02 is the company’s intravenously administered multi-phage product for the treatment of complicated bacteremia caused by Staphylococcus aureus. The designation underscores the potential of the candidate drug to improve upon current standards and care of treatment for complicated Staphylococcus aureus bacteremia SAB.

The designation is designed to facilitate and expedite the review of investigational therapies for serious conditions with tremendous potential. It also paves the way for the rolling of a Biologic License Application and eligibility for Accelerated Approval and Priority Review.

Following the designation, Armata Pharmaceutical is poised to pursue a Phase 3 superiority study set for the second half of the year. The company has already entered into a secured credit agreement with Innoviva Strategic Opportunities for a $25 million loan. Proceeds from the transaction will be used to finance the development of AP-SA02.

Armata Pharmaceuticals Inc. (NYSE:ARMP) is a clinical-stage biotechnology company developing precisely targeted, pathogen-specific bacteriophage (phage) therapeutics to treat antibiotic-resistant and difficult-to-treat bacterial infections. Their mission is to combat the global antibiotic resistance crisis while preserving the healthy human microbiome.

11. SKYX Platforms Corp. (NASDAQ:SKYX)

Market Capitalization: $145.76 Million

Expected 5-Year Earnings Growth: 68.50%

Number of Hedge Fund Holders: 8

Stock Upside Potential: 324.53%

SKYX Platforms Corp (NASDAQ:SKYX) is one of the high-growth micro-cap stocks to buy now. On June 10, SKYX Platforms Corp (NASDAQ:SKYX) confirmed it is poised to deploy its advanced smart technologies as part of a comprehensive renovation of The Mozart Prague, an iconic 5-star hotel in the Czech Republic.

SKYX Platforms Corp is to supply its advanced smart plug-and-play technologies, including ceiling lighting, ceiling fans, emergency lights, and outdoor lights, among others. The integration of technologies is expected to improve the quality of life and safety standards in hotels and buildings, while also reducing costs.

Similarly, SKYX Platforms has also inked a licensing agreement with lighting company Eurofase to distribute its ceiling electrical outlets and smart home technologies across the builder and commercial segments. Eurofase is to incorporate the company’s ceiling electrical outlet technology into its product offerings that it currently distributes in the US, Canada, Europe, and Asia.

SKYX Platforms Corp. (NASDAQ:SKYX) is a technology company specializing in plug-and-play platform technologies that make electrical installations such as light fixtures and ceiling fans safer and smarter. Their core mission is to establish enhanced safety and intelligence as the new standard for homes and buildings.